aluminum sulfate has been researched along with Koch's Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldwin, SL; Coler, RN; Fox, CB; Lin, S; Lucas, E; Moon, JJ; Orr, MT; Phan, T; Reed, SG; Sivananthan, SJ; Vedvick, TS | 1 |
Acosta, A; Aguilar, A; Alvarez, N; Borrero, R; Camacho, F; Espinoza, DM; Fernández, S; Hernández-Pando, R; Norazmi, MN; Payán, JA; Pérez, JL; Puig, A; Reyes, F; Sarmiento, ME; Tirado, Y | 1 |
Acosta, A; Alvarez, N; Borrero, R; Fernandez, S; Garcia, MA; Kadir, R; Norazmi, MN; Perez Quinoy, JL; Puig, A; Reyes, F; Reyes, G; Rodriguez, L; Sarmiento, ME; Tirado, Y | 1 |
Agger, EM; Andersen, P; Kamath, AT; Lambert, PH; Lingnau, K; Rochat, AF; Siegrist, CA; Valenti, MP; von Gabain, A | 1 |
4 other study(ies) available for aluminum sulfate and Koch's Disease
Article | Year |
---|---|
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Female; Glucosides; Humans; Immunization; Lipids; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Th1 Cells; Toll-Like Receptor 4; Tuberculosis; Tuberculosis Vaccines | 2013 |
Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Bacterial Load; Disease Models, Animal; Lung; Male; Mice, Inbred BALB C; Mycobacterium bovis; Mycobacterium tuberculosis; Proteolipids; Tuberculosis; Tuberculosis Vaccines | 2015 |
Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Bacterial; Antigens, Bacterial; Cell Wall; Cross Reactions; Female; Immunoglobulin G; Mice; Mice, Inbred BALB C; Mycobacterium bovis; Mycobacterium smegmatis; Mycobacterium tuberculosis; Proteolipids; Tuberculosis; Tuberculosis Vaccines | 2011 |
Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigen Presentation; Antigens, Bacterial; Antigens, CD; Bacterial Proteins; CD11c Antigen; CD4-Positive T-Lymphocytes; Cell Proliferation; Dendritic Cells; Interferon-gamma; Interleukin-12 Subunit p40; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mycobacterium bovis; Oligodeoxyribonucleotides; Ovalbumin; Recombinant Fusion Proteins; Spleen; T-Lymphocytes; Tuberculosis; Vaccination | 2008 |